Evidence map›Paper›PMID 39768035›Full record

ArticleBioengineering (Basel, Switzerland)2024

Breast Tumor Detection and Diagnosis Using an Improved Faster R-CNN in DCE-MRI.

Haitian Gui, Han Jiao, Li Li, Xinhua Jiang, Tao Su, Zhiyong Pang

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Haitian GuiSchool of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.ORCID 0000-0001-8827-9154
Han JiaoSchool of Electronics and Information Technology, Sun Yat-sen University, Guangzhou 510006, China.
Li LiState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Medical Imaging, Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou 510060, China.
Xinhua JiangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Medical Imaging, Sun Yat-sen University Cancer Center (SYSUCC), Guangzhou 510060, China.
Tao SuSchool of Electronics and Information Technology, Sun Yat-sen University, Guangzhou 510006, China.ORCID 0000-0001-5227-1337
Zhiyong PangSchool of Electronics and Information Technology, Sun Yat-sen University, Guangzhou 510006, China.

Funding

GuangDong Basic and Applied Basic Research Foundation 2024A1515012246
6 · The paper itself

Abstract

AI-based breast cancer detection can improve the sensitivity and specificity of detection, especially for small lesions, which has clinical value in realizing early detection and treatment so as to reduce mortality. The two-stage detection network performs well; however, it adopts an imprecise ROI during classification, which can easily include surrounding tumor tissues. Additionally, fuzzy noise is a significant contributor to false positives. We adopted Faster RCNN as the architecture, introduced ROI aligning to minimize quantization errors and feature pyramid network (FPN) to extract different resolution features, added a bounding box quadratic regression feature map extraction network and three convolutional layers to reduce interference from tumor surrounding information, and extracted more accurate and deeper feature maps. Our approach outperformed Faster R-CNN, Mask R-CNN, and YOLOv9 in breast cancer detection across 485 internal cases. We achieved superior performance in mAP, sensitivity, and false positive rate ((0.752, 0.950, 0.133) vs. (0.711, 0.950, 0.200) vs. (0.718, 0.880, 0.120) vs. (0.658, 0.680, 405)), which represents a 38.5% reduction in false positives compared to manual detection. Additionally, in a public dataset of 220 cases, our model also demonstrated the best performance. It showed improved sensitivity and specificity, effectively assisting doctors in diagnosing cancer.

Indexed as

AI assistantbreast cancer detectiondeep learning

Identifiers

PMID39768035
PMCPMC11673413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.